Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2025 Earnings Call Transcript May 7, 2025
Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $0.52, expectations were $0.47.
Operator: Hello, and welcome to the Q1 2025 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex, and I’ll be coordinating the call today. [Operator Instructions]. I’ll now hand it over to your host, Christopher Stevo, Head of Investor Relations to begin....
